Concepedia

Michael H. Weisman

MH

Statistics

Publications

266

Citations

33.5K

H-Index

88

Active since

1967

Affiliations

Cedars-Sinai Medical Center(Current)

University of California, Los Angeles

University of California San Diego

University of California, San Francisco

The University of Texas Health Science Center at Houston

Michael H. Weisman is an author at Cedars-Sinai Medical Center specializing in rheumatology, medicine, and autoimmunity.

ORCID

Publications per year

1967–2025

266

Publications

266

Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis

Peter E. Lipsky, Désirée van der Heijde, E. William St. Clair et al. · New England Journal of Medicine · 2000 · 3K citations · Full text

, , +14

Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

Ravinder N. Maini, E. William St. Clair, Ferdinand C. Breedveld et al. · The Lancet · 1999 · 2.4K citations

, , +17

The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment

Ferdinand C. Breedveld, Michael H. Weisman, Arthur F. Kavanaugh et al. · Arthritis & Rheumatism · 2005 · 1.8K citations

, , +17

Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial

Michael E. Weinblatt, Edward Keystone, Daniel E. Furst et al. · Arthritis & Rheumatism · 2003 · 1.8K citations

, , +15

Glucosamine, Chondroitin Sulfate, and the Two in Combination for Painful Knee Osteoarthritis

Daniel O. Clegg, Domenic J. Reda, Crystal L. Harris et al. · New England Journal of Medicine · 2006 · 1.3K citations · Full text

, , +11

1–5 of 266